Stay updated on Oncolytics Biotech Press Releases
Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.

Latest updates to the Oncolytics Biotech Press Releases page
- Check7 days agoChange DetectedThe cookie consent banner and related controls (Accept All, Reject All, Customize, Manage Consent) are removed from the News page. This change affects only the site's UI/privacy prompt and does not alter the investor news content or data.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNew press releases added for November 20, 2025 and November 19, 2025. Older items are removed and the page count changes from Page 1 of 68 to Page 1 of 69.SummaryDifference6%

- Check35 days agoChange DetectedThe News page adds a press release about establishing a Gastrointestinal Tumor Scientific Advisory Board (Nov 4, 2025) and removes the previous press release about voluntary delisting from the Toronto Stock Exchange (Aug 8, 2025).SummaryDifference1%

- Check43 days agoChange DetectedAdded a new press release entry to the News page: 'Oncolytics Biotech® Reports Updated Anal Cancer Data Showing Objective Response Rate More Than Double the Current Standard of Care' (October 28, 2025).SummaryDifference1%

- Check64 days agoChange DetectedUpdated the organization’s address from Calgary, Alberta to San Diego, California, including a new street address and suite number; old Calgary details were removed and replaced with San Diego details.SummaryDifference6%

- Check71 days agoChange DetectedShift from an older event highlight and consent note to a newer forward-looking pancreatic cancer registration study announcement.SummaryDifference12%

Stay in the know with updates to Oncolytics Biotech Press Releases
Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.